Home > Products > CD28 & HN > Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scIgG)

Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scIgG)  (SCIGG-H237)

Recombinant Anti-CD28 x Anti-HN Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD28 and anti-HN IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the tumor vaccine modification and the research of Tumors therapy.

Specifications

Targets
CD28 & HN
Type
Single chain IgGs
Species Reactivity
Human
Target 1
CD28
Host Animal 1
Human
Target 2
HN
Host Animal 2
Human
Application
FuncS; Promising preventive/therapeutic agent
Related Disease
Tumors

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
HN
Gene ID
UniProt ID
Alternative Names
Hemagglutinin-neuraminidase; HN

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scIgG) (SCIGG-H237). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD28 & HN"
See other bsAb targets related to "CD28"

See other bsAb targets related to "HN"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: